GLOW

COMPOUND OVERVIEW

The GLOW Blend is a premium tri-peptide research formulation combining three of the most extensively studied regenerative and tissue-remodeling compounds: GHK-Cu (Copper Peptide), BPC-157, and Thymosin Beta 4 (TB500). Each component independently demonstrates potent effects on tissue repair, anti-inflammatory signaling, and cellular regeneration — but their combination targets the biological processes of skin, connective tissue, and systemic repair through three distinct yet complementary mechanisms. The GLOW Blend was formulated to serve as a comprehensive regenerative research protocol in a single vial, named for its dermatological and systemic tissue renewal research applications.

MECHANISM OF ACTION

GHK-Cu drives collagen and elastin synthesis, resets fibroblast gene expression toward youthful profiles, and provides antioxidant and anti-inflammatory activity. BPC-157 promotes angiogenesis through VEGF and NO upregulation, accelerates tissue repair via FAK-paxillin signaling, and provides gastroprotective and systemic cytoprotective effects. TB500 sequentially supports cell migration to repair sites through actin cytoskeleton regulation, activates the Akt/PI3K survival pathway, and promotes VEGF-driven vascularization. Together, the three compounds address tissue repair at the molecular (gene expression), cellular (migration, survival), and vascular (angiogenesis) levels simultaneously.

RESEARCH APPLICATIONS

• Comprehensive skin tissue remodeling and collagen synthesis research
• Multi-mechanism wound healing and repair studies
• Anti-aging at the cellular and extracellular matrix level
• Angiogenesis and vascularization research
• Post-injury systemic tissue recovery research protocols
• Combination peptide synergy and additive effect studies
• Dermatological and connective tissue research

KEY RESEARCH FINDINGS

• Individual component studies: GHK-Cu modulates 4,000+ genes in aged fibroblasts, BPC-157 accelerates tendon-to-bone healing, TB500 promotes cardiac and wound tissue regeneration
• Angiogenesis research supports the combined VEGF-stimulating activity of both BPC-157 and TB500
• Anti-inflammatory research confirms convergent suppression of TNF-alpha, IL-1β, and NF-kB pathways across all three components
• Collagen synthesis studies show GHK-Cu synergizes with growth factor signaling promoted by BPC-157
• Cell migration and wound closure research demonstrates TB500 and BPC-157 target complementary cellular events in the repair cascade
• Researchers studying multi-peptide regenerative protocols note the GLOW Blend targets early (angiogenesis, inflammation) and late (matrix remodeling, fibroblast programming) stages of tissue repair

STORAGE & HANDLING

• Store lyophilized co-formulation at -20°C; stable up to 24 months
• Reconstitute with bacteriostatic water; store at 2–8°C; use within 28 days
• Blue-green tint from GHK-Cu is normal and expected
• Avoid light exposure — both GHK-Cu and BPC-157 are light-sensitive
• Handle with sterile technique; protect reconstituted solution from oxidation

SPECIFICATIONS

DISCLAIMER: This compound is sold strictly for laboratory and research purposes only. It is not intended for human consumption, clinical use, or veterinary application. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. For use by licensed researchers and qualified professionals only. You must be 21 years of age or older to purchase.

usaminopeptides.com · For Researcher Inquiries Contact: info@usaminopeptides.com